# The Global Alliance for TB Drug Development Inc.

Canonical: https://abierto.us/vendors/the-global-alliance-for-tb-drug-development-inc-ca1rnresazu6

- UEI: CA1RNRESAZU6
- CAGE: 52VM4
- Location: New York, NY
- Awards in window: 1 (5 transactions), $2,475,623 obligated, May 9, 2024 to August 26, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $2,475,623

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $2,475,623

## Competition

- Full and Open Competition: 1 awards

## Solicitations won

- 2023 NIAID Omnibus Broad Agency Announcement (HHS-NIH-NIAID-BAA2023-1), $9,851,406. https://abierto.us/opportunities/hhsnihniaidbaa20231

## Largest awards

- 75N93024C00008 (definitive contract): $2,475,623, National Institutes of Health Niaid. To Develop a Novel Modulator Targeting Proteostasis for the Treatment of M. Tuberculosis.. https://www.usaspending.gov/award/CONT_AWD_75N93024C00008_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/the-global-alliance-for-tb-drug-development-inc-ca1rnresazu6.